Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Other Working Capital Changes: 2020-2025

Historic Other Working Capital Changes for Caribou Biosciences (CRBU) over the last 5 years, with Sep 2025 value amounting to -$576,000.

  • Caribou Biosciences' Other Working Capital Changes fell 112.33% to -$576,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 166.38%. This contributed to the annual value of $3.9 million for FY2024, which is 123.22% up from last year.
  • Caribou Biosciences' Other Working Capital Changes amounted to -$576,000 in Q3 2025, which was up 36.00% from -$900,000 recorded in Q2 2025.
  • Over the past 5 years, Caribou Biosciences' Other Working Capital Changes peaked at $30.0 million during Q1 2021, and registered a low of -$21.6 million during Q3 2023.
  • For the 3-year period, Caribou Biosciences' Other Working Capital Changes averaged around -$1.4 million, with its median value being -$606,000 (2023).
  • Within the past 5 years, the most significant YoY rise in Caribou Biosciences' Other Working Capital Changes was 286.99% (2023), while the steepest drop was 2,572.61% (2023).
  • Caribou Biosciences' Other Working Capital Changes (Quarterly) stood at -$1.0 million in 2021, then slumped by 51.84% to -$1.6 million in 2022, then surged by 61.33% to -$606,000 in 2023, then soared by 228.71% to $780,000 in 2024, then crashed by 112.33% to -$576,000 in 2025.
  • Its Other Working Capital Changes was -$576,000 in Q3 2025, compared to -$900,000 in Q2 2025 and -$996,000 in Q1 2025.